kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports Uncovering new therapeutic targets for
Uncovering new therapeutic targets for a common KRAS mutation behind cancer KRAS Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions PMC What should we know about the 'undruggable' target KRAS? MedChemExpress KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology The KRAS G12D mutation induces metabolic vulnerability in B cell acute lymphoblastic leukemia ScienceDirect
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20




